The previous studies have indicated that EHF acts as an oncosuppressor in prostate cancer and ESCC [11, 13, 14], whereas our data suggest that EHF may have a putative oncogenic function in thyroid cancer. The gene discussed is EHF; the disease is esophageal squamous cell carcinoma.